< Previous page
All
Airlines/Aviation
Auto
Maritime/Shipbuilding
Transportation
Computer Hardware
Computer Networks
Computer Software
Computer/Electronics
Electronic Commerce
Electronic Components
High Tech Security
Internet Technology
Peripherals
Semiconductors
Electronics Gaming
Consumer Electronics
Mobile Entertainment
Multimedia/Online/Internet
Telecommunications
Household/Consumer/Cosmetics
Retail
Supermarkets
Toys
Alternative Energies
Chemical
Mining/Metals
Oil/Energy
Environmental Products & Services
Green Technology
Art
Cosmetics & Personal Care
Entertainment
Fashion
Film & Motion Picture
Jewelry
Banking/Financial Service
Insurance
Workforce Management/Human Resources
Education
Higher Education
Biotechnology
Health Care/Hospital
Infectious Disease Control
Medical Equipment
Medical/Pharmaceuticals
Agriculture
Machinery
Paper/Forest Products/Containers
Textiles
Domestic policy
Legal issues
Sports
Hotels and Resorts
Leisure/Travel/Hotels
Travel
Restaurants
Beer, Wine & Spirits
Beverages
Non-Alcoholic Beverages
Food/Beverages
Advertising
Books
Music
Publishing/Information Service
Television
Trade show news
Real Estate
Construction/Building
Furniture & Furnishings
|
Title only
|
Print
Next page >
88IV - PR Newswire Asia's news - Health Care/Hospital
5
Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH
SUZHOU, China and MÖLNDAL, Sweden , July 2, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. (06938.HK), and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo"), ...
2026-07-02T
Biotechnology
Health Care/Hospital
Medical/Pharmaceuticals
Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC
SHANGHAI , July 2, 2026 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) today announced that it has entered into a strategic collaboration ...
2026-07-02T
Biotechnology
Health Care/Hospital
Medical/Pharmaceuticals
Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-Class Single-Domain Antibody-Based BBB-Crossing Technology for CNS Diseases
CAMBRIDGE, Mass. , July 2, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, ...
2026-07-02T
Biotechnology
Health Care/Hospital
Medical/Pharmaceuticals
Bredehorst Clinic Medical Management, Germany's Leading Healthcare Procurement Specialist, partners with Sigla
DÜSSELDORF, Germany , July 1, 2026 /PRNewswire/ -- Düsseldorf - Sigla , a European private equity firm, is pleased to announce its investment in Bredehorst Clinic Medical Management GmbH ...
2026-07-01T
Banking/Financial Service
Computer/Electronics
Health Care/Hospital
NYSE Content Update: Mobility Global Marks First Day as Public Company
NYSE issues a pre-market daily advisory direct from the trading floor. ...
2026-07-01T
Banking/Financial Service
Computer/Electronics
Health Care/Hospital
STARMED Receives FDA 510(k) Clearance for a Benign Thyroid Nodule Ablation Indication
SEOUL, South Korea , July 1, 2026 /PRNewswire/ -- STARMED, a medical device company specialising in minimally invasive treatment technologies, has announced that it has obtained 510(k) clearance from ...
2026-07-01T
Health Care/Hospital
Medical Equipment
Medical/Pharmaceuticals
Vitafoods Asia 2026: Science-Backed Botanicals and Next-Generation Probiotics Take Centre Stage
Leading Companies Present Science-Backed Solutions Addressing Antimicrobial Resistance, Digestive Health, and Wellness Through Advanced Probiotics and Clinical Botanicals ...
2026-07-01T
Health Care/Hospital
Medical/Pharmaceuticals
PharmaResearch Accelerates REJURAN Cosmetics Expansion Across North and South America with Planned Acquisition of CG USA
Acquisition strengthens local manufacturing and logistics capabilities as REJURAN Cosmetics expands across Sephora, Amazon and Canada, with future growth across the Americas in view ...
2026-07-01T
Biotechnology
Computer/Electronics
Cosmetics & Personal Care
Health Care/Hospital
The Hidden Cost of Efficiency: How Singapore Professionals Manage "Chronic Low-Grade Fatigue"
SINGAPORE , July 1, 2026 /PRNewswire/ -- With locals working an average of 43–45 hours per week, Singapore professionals face widespread "chronic low-grade fatigue." Research in the Journal ...
2026-07-01T
Health Care/Hospital
Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing
The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer that has driven 80% population declines across ...
2026-07-01T
Biotechnology
Computer/Electronics
Environmental Products & Services
Health Care/Hospital
< Previous page
Next page >
Disclaimer :
In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.